-
1 Comment
Imricor Medical Systems, Inc is currently in a long term downtrend where the price is trading 14.3% below its 200 day moving average.
From a valuation standpoint, the stock is 3.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 247.7.
Imricor Medical Systems, Inc's total revenue sank by 27.4% to $425K since the same quarter in the previous year.
Its net income has increased by 19.3% to $-7M since the same quarter in the previous year.
Finally, its free cash flow fell by 85.0% to $-4M since the same quarter in the previous year.
Based on the above factors, Imricor Medical Systems, Inc gets an overall score of 2/5.
Exchange | AU |
---|---|
CurrencyCode | AUD |
Industry | Medical Devices |
ISIN | AU0000054942 |
Sector | Healthcare |
Target Price | 2.2571 |
---|---|
Market Cap | 565M |
Beta | -0.2 |
PE Ratio | None |
Dividend Yield | None |
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for IMR.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025